Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
22 studies found for:    Open Studies | "Hyponatremia"
Show Display Options
Rank Status Study
1 Recruiting Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia
Condition: Hyponatremia
Intervention: Other: Neuropsychological and motoric tests
2 Not yet recruiting Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
Condition: Hyponatremia
Intervention:
3 Recruiting A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
Condition: Hyponatremia
Interventions: Drug: Tolvaptan;   Other: Placebo
4 Recruiting Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic Hyponatremia
Condition: Hyponatremia
Intervention: Drug: Tolvaptan
5 Recruiting An Extension Follow-up Trial to Evaluate the Long-term Safety of Children and Adolescent Subjects With Euvolemic or Hypervolemic Hyponatremia
Condition: Hyponatremia
Intervention: Drug: Tolvaptan
6 Recruiting Efficacy and Safety of Rapid Intermittent Compared With Slow Continuous Correction in Severe Hyponatremia Patients
Condition: Hyponatremia Symptomatic
Intervention: Drug: 3% hypertonic saline
7 Recruiting Characterization of Neuropsychologic and Physical Performance in Geriatric Patients With Hyponatremia.
Condition: Hyponatremia
Intervention: Other: Multidimensional Geriatric Assessment (MGA)
8 Recruiting Outcome and Treatment Quality Study of Tolvaptan to Treat Hyponatremia in Patients With Heart Failure
Condition: Heart Failure With Hyponatremia
Interventions: Drug: Tolvaptan;   Drug: Placebo
9 Recruiting An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy
Conditions: Hyponatremia;   Syndrome of Inappropriate ADH (SIADH) Secretion;   Cancer
Intervention:
10 Recruiting Protein Supplementation in Thiazide-induced Hyponatremia
Conditions: Hyponatremia;   Hypertension;   Blood Pressure
Intervention: Dietary Supplement: Nepro
11 Recruiting The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia
Conditions: Heart Failure;   Hyponatremia
Intervention: Other: Fluid restriction
12 Not yet recruiting The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
Conditions: Hyponatremia;   SIADH
Intervention:
13 Recruiting Tolvaptan for Patients With Acute Neurological Injuries
Conditions: Hyponatremia;   SIADH
Intervention: Drug: Tolvaptan
14 Recruiting Comparison of Ringer Lactate and Isotonic Acetate Solution as Perioperative Maintenance Fluid for Children
Condition: Hyponatremia
Interventions: Biological: Ringer Lactate;   Biological: Plasmalyte
15 Recruiting Samsca Post Marketing Surveillance Study
Condition: Hypervolemic and Euvolemic Hyponatremia
Intervention:
16 Recruiting Tolvaptan for Advanced or Refractory Heart Failure
Conditions: Heart Failure;   Hyponatremia
Interventions: Drug: Tolvaptan;   Drug: Standard of care diuretic therapy
17 Recruiting Regional Tolvaptan Registry
Conditions: Decompensated Heart Failure;   Hyponatremia
Interventions: Drug: Tolvaptan;   Other: No intervention
18 Recruiting Post-Operative Water Load Following Transsphenoidal Pituitary Surgery
Conditions: Hyponatremia;   Pituitary Adenoma
Intervention: Other: Water Load (WL) Post-Operative Day 1
19 Recruiting Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage:
Conditions: Subarachnoid Hemorrhage;   Cerebral Vasospasm;   Hyponatremia
Interventions: Drug: HTS 3%;   Drug: Standard fluid management
20 Not yet recruiting Intravenous Fluids in Hospitalised Children
Conditions: Hypokalemia;   Hyponatremia;   Hypernatremia;   Dehydration
Interventions: Drug: Plasmalyte Glucos 50 mg/mL;   Drug: 0.45% saline in 5% dextrose

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.